{"id":"W2574014792","doi":"10.1016/j.leukres.2017.01.023","title":"Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada); St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; Royal Columbian Hospital; University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Fludarabine; Medicine; Rituximab; Hazard ratio; Internal medicine; Chemoimmunotherapy; Population; Chronic lymphocytic leukemia; Confidence interval; Regimen; Proportional hazards model; Oncology; Cohort; Alemtuzumab; Vincristine; Surgery; Cyclophosphamide; Chemotherapy; Leukemia; Transplantation; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007000712,0.0001651771,0.0007410896,0.0002629404,0.0002000145,0.0001030546,0.0002599899,0.0001482899,0.00002136375],"category_scores_gemma":[0.001509545,0.0001930048,0.00004360036,0.0003883036,0.0002697982,0.0001133008,0.0001005917,0.0002001833,3.73858e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2197174,"about_ca_system_score_gemma":0.1139638,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9871023,"about_ca_topic_score_gemma":0.9849136,"domain_scores_codex":[0.9971138,0.0001280651,0.0006617606,0.0005271279,0.0008892518,0.0006799693],"domain_scores_gemma":[0.9974177,0.0007457357,0.0002702263,0.0007577767,0.0006320801,0.0001765227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003944539,0.0000677916,0.9922909,0.0007481569,0.00005349807,0.00004865258,0.00003758538,0.0004274167,0.001407097,0.000001529732,0.000008048756,0.00451484],"study_design_scores_gemma":[0.03379462,0.001089361,0.923004,0.000850087,0.00002943123,0.000007330003,0.00001875706,0.04016242,0.0008667661,0.00001041716,0.00002270592,0.0001440718],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965726,0.0000489026,0.00000496032,0.00002365946,0.00002922985,0.003075858,0.0001590288,0.000008987301,0.000076841],"genre_scores_gemma":[0.9984131,0.00003317804,0.0002180676,0.00001176407,0.00002766952,0.0004336567,0.0003283405,0.00004874279,0.0004854868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1057535,"threshold_uncertainty_score":0.8910592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03724798008251208,"score_gpt":0.3164581650059118,"score_spread":0.2792101849233997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}